Persistence, Adherence, and Switching to Higher-Cost Therapy in Patients with Multiple Sclerosis Initiating Oral Disease-Modifying Therapies: A Retrospective Real-World Study
posted on 2022-09-16, 09:30authored byAdis journals on behalf of, Lita Araujo, Svend S Geertsen, Allen Amedume, Keiko Higuchi, Janneke van Wingerden
The above graphical abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).